SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-17-000032
Filing Date
2017-05-02
Accepted
2017-05-02 07:38:23
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q q1201710-q.htm 10-Q 868746
2 EXHIBIT 31.1 q12017exhibit311.htm EX-31.1 12534
3 EXHIBIT 31.2 q12017exhibit312.htm EX-31.2 12594
4 EXHIBIT 32.1 q12017exhibit321.htm EX-32.1 6821
5 EXHIBIT 32.2 q12017exhibit322.htm EX-32.2 6737
12 may2017pipeline.jpg GRAPHIC 213877
  Complete submission text file 0001367920-17-000032.txt   4387391

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20170331.xml EX-101.INS 763124
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20170331.xsd EX-101.SCH 32909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20170331_cal.xml EX-101.CAL 54716
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20170331_def.xml EX-101.DEF 158670
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20170331_lab.xml EX-101.LAB 432531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20170331_pre.xml EX-101.PRE 271487
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 17802922
SIC: 2834 Pharmaceutical Preparations